Skip to main content
. 2021 Sep 10;24(10):103110. doi: 10.1016/j.isci.2021.103110

Table 2.

Number of predicted drugs for each biomass reaction corresponding to approved antineoplastic drugs according to SEER∗RX database

Input model R_generic biomass Human1_genbiomass iHsa_gen biomass R3_main biomass R3_noTrTr biomass R3_renal biomass HMR_gen biomass
Recon2 19 (45.24%) 22 (22.68%) 14 (17.5%) 2 (5.13%) 1 (8.33%) 22 (22.68%) 12 (19.35%)
Home models 1 (25%) 38 (26.39%) 49 (34.03%) 1 (25%) 1 (50%) 1 (20%) 31 (21.09%)